Transforming Pulmonary Disease Outcomes
ProterixBio is currently developing disease management platforms for pulmonary diseases, with an initial focus on COPD. Additional areas of pulmonary research include CF (cystic fibrosis) and IPF (idiopathic pulmonary fibrosis). Chronic pulmonary diseases share some common disease processes. ProterixBio’s development strategy leverages this commonality in the design of our biomarker panels, clinical studies, and data analysis methods.